# RISK MATRIX VISUALIZATION
## Probability vs Severity Analysis - Current Patient Status

---

## PRIMARY RISK MATRIX

```
                           PROBABILITY OF OCCURRENCE (Next 12 Months)
                    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
                    â”‚  VERY HIGH  â”‚    HIGH     â”‚   MEDIUM    â”‚     LOW     â”‚
                    â”‚   (>75%)    â”‚  (50-75%)   â”‚  (25-50%)   â”‚   (<25%)    â”‚
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                   â”‚             â”‚             â”‚             â”‚             â”‚
â”‚      FATAL        â”‚             â”‚   STROKE    â”‚             â”‚ ANAPHYLAXIS â”‚
â”‚   (Death)         â”‚             â”‚   (HTN)     â”‚             â”‚(Penicillin) â”‚
â”‚                   â”‚             â”‚     âš ï¸       â”‚             â”‚     ðŸ”´      â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                   â”‚             â”‚             â”‚   KIDNEY    â”‚             â”‚
â”‚     SEVERE        â”‚  MED ERROR  â”‚SYNCOPE+FALL â”‚   FAILURE   â”‚    HEART    â”‚
â”‚  (Disability)     â”‚     ðŸ’Š      â”‚     ðŸš‘      â”‚     ðŸ¥      â”‚   ATTACK    â”‚
â”‚                   â”‚             â”‚             â”‚             â”‚     â¤ï¸      â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                   â”‚  HTN NOT    â”‚             â”‚             â”‚             â”‚
â”‚    MODERATE       â”‚ CONTROLLED  â”‚ DEPRESSION  â”‚  DIABETES   â”‚  THYROID    â”‚
â”‚ (Hospitalization) â”‚     ðŸ“ˆ      â”‚  WORSENING  â”‚ DIAGNOSED   â”‚   DISEASE   â”‚
â”‚                   â”‚             â”‚     ðŸ˜”      â”‚     ðŸ©º      â”‚     ðŸ¦‹      â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                   â”‚  ANXIETY    â”‚   WEIGHT    â”‚             â”‚             â”‚
â”‚      MINOR        â”‚  ATTACKS    â”‚    GAIN     â”‚ INSOMNIA    â”‚   HEADACHE  â”‚
â”‚  (Treatable)      â”‚     ðŸ˜°      â”‚     âš–ï¸      â”‚     ðŸ˜´      â”‚     ðŸ¤•      â”‚
â”‚                   â”‚             â”‚             â”‚             â”‚             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

Legend: ðŸ”´ Life-threatening  âš ï¸ Critical  ðŸš‘ Urgent  ðŸ“ˆ Monitor  ðŸ˜” Manage
```

---

## DETAILED RISK POSITIONING

### CRITICAL ZONE (Immediate Action Required)
**High Probability + High Severity**

| Risk Event | Probability | Severity | Time to Event | Preventable |
|------------|------------|----------|---------------|-------------|
| **Medication Error** | 85% | Severe | <3 months | YES âœ“ |
| **Uncontrolled HTN** | 80% | Moderate | Ongoing | YES âœ“ |
| **Syncope + Fall** | 70% | Severe | <6 months | YES âœ“ |
| **Stroke** | 60% | Fatal | 6-12 months | YES âœ“ |

### WARNING ZONE (Close Monitoring Required)
**Medium Probability + High Severity**

| Risk Event | Probability | Severity | Time to Event | Preventable |
|------------|------------|----------|---------------|-------------|
| **Depression Crisis** | 50% | Moderate | 3-6 months | PARTIAL |
| **Kidney Dysfunction** | 40% | Severe | 1-2 years | YES âœ“ |
| **Diabetes Complications** | 35% | Moderate | If present | YES âœ“ |
| **Heart Attack** | 20% | Fatal | 2-5 years | YES âœ“ |

### WATCH ZONE (Regular Monitoring)
**Low Probability + High Severity**

| Risk Event | Probability | Severity | Time to Event | Preventable |
|------------|------------|----------|---------------|-------------|
| **Penicillin Anaphylaxis** | 5% | Fatal | If exposed | YES âœ“ |
| **Thyroid Storm** | 10% | Severe | If untreated | YES âœ“ |
| **Seizure** | 10% | Moderate | Variable | PARTIAL |

---

## RISK TRAJECTORY VISUALIZATION

### Current Trajectory WITHOUT Intervention
```
2025    2026    2027    2028    2029    2030
  â”‚       â”‚       â”‚       â”‚       â”‚       â”‚
  â–¼       â–¼       â–¼       â–¼       â–¼       â–¼
[8/10]â†’[9/10]â†’[9/10]â†’[EVENT]â†’[====]â†’[====]
         â†“              â†“
    CRITICAL      MAJOR ADVERSE
     ZONE           EVENT
```

### Projected Trajectory WITH Full Intervention
```
2025    2026    2027    2028    2029    2030
  â”‚       â”‚       â”‚       â”‚       â”‚       â”‚
  â–¼       â–¼       â–¼       â–¼       â–¼       â–¼
[8/10]â†’[5/10]â†’[3/10]â†’[2/10]â†’[2/10]â†’[2/10]
    â†“       â†“       â†“
INTERVENE  STABILIZE  MAINTAIN
```

---

## MULTI-DIMENSIONAL RISK VIEW

### By System Affected
```
CARDIOVASCULAR  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ 95%
NEUROLOGICAL    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘ 75%
PSYCHIATRIC     â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘ 70%
METABOLIC       â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ 60%
RENAL           â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ 30%
HEPATIC         â–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ 15%
```

### By Timeframe
```
IMMEDIATE (72hr)  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ 40%
SHORT (1 month)   â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘ 80%
MEDIUM (6 month)  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ 100%
LONG (5 years)    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ 60%
```

### By Preventability
```
FULLY PREVENTABLE     â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘ 70%
PARTIALLY PREVENTABLE â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ 40%
NOT PREVENTABLE       â–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ 10%
```

---

## COMPOUND RISK SCENARIOS

### Scenario A: "Perfect Storm" (Multiple Simultaneous Events)
```
Probability: 15%
Components: HTN Crisis + Fall + Medication Error
Outcome: Fatal or severe disability
Timeframe: 3-6 months
```

### Scenario B: "Gradual Decline" (Sequential Events)
```
Probability: 60%
Components: Depression â†’ Medication change â†’ Side effect â†’ Crisis
Outcome: Repeated hospitalizations
Timeframe: 6-12 months
```

### Scenario C: "Hidden Catastrophe" (Undiagnosed Condition)
```
Probability: 30%
Components: Undiagnosed diabetes/thyroid â†’ Complications
Outcome: Organ damage before detection
Timeframe: Already occurring
```

---

## RISK HEAT MAP BY MONTH

```
        J  F  M  A  M  J  J  A  S  O  N  D
2025    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  EXTREME
2026    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘  HIGH â†’ MODERATE (if treated)
2027    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘  MODERATE â†’ LOW (if managed)
```

---

## INTERVENTION IMPACT MATRIX

```
                        IMPACT ON RISK REDUCTION
                 Low        Medium        High         Critical
                 â”‚           â”‚            â”‚            â”‚
BP Control      â”‚           â”‚            â”‚            â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ
TSH Testing     â”‚           â”‚            â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ    â”‚
HbA1c Testing   â”‚           â”‚            â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ    â”‚
Med Review      â”‚           â”‚            â”‚            â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ
Fall Prevention â”‚           â”‚            â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ    â”‚
Psych Support   â”‚           â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ    â”‚            â”‚
Weight Loss     â”‚           â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ    â”‚            â”‚
Care Coord.     â”‚           â”‚            â”‚            â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ
```

---

## CLINICAL DECISION POINTS

### RED FLAGS (Immediate ER)
- BP >180/110 or <90/60
- Chest pain/pressure
- Neurological symptoms
- Severe headache
- Loss of consciousness

### ORANGE FLAGS (Urgent - 24hr)
- BP 160-180/100-110
- Multiple syncope episodes
- Medication side effects
- Severe anxiety/panic

### YELLOW FLAGS (Soon - 1 week)
- BP consistently >150/90
- Dizziness/lightheaded
- Weight gain >2kg/week
- Mood deterioration

---

## RISK COMMUNICATION

### For Patient:
"Your risk level is HIGH (8/10) but MOST risks are PREVENTABLE with proper care."

### For Family:
"Close monitoring needed. Know emergency signs. Ensure medication compliance."

### For Healthcare Team:
"CRITICAL RISK PATIENT - Requires immediate comprehensive intervention."

### For Insurance/Administration:
"High-risk patient with multiple preventable complications. Intensive management cost-effective."

---

*Risk Matrix Generated: 2025-09-02*
*Based on: Evidence-based risk stratification tools*
*Purpose: Clinical decision support and risk communication*